Posted on 27-Nov-2015 by Dr. Nadeem Khan
DMPK has become a tool to optimize ADME properties in drug designing and screening. However, there are many related questions that often boggle the mind of a drug developer. Most importantly, there is a need to identify appropriate ADME tests required to conduct for preclinical studies. As a result, a few clarifications have become mandatory before initiating the ADME program 1. What should a representative... Continue Reading